Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for depression, but sexual side effects often compromise compliance. These reproductive dysfunctions are likely mediated by elevations of the hormone prolactin. Yet, how serotonin (5-HT) and SSRIs cause changes in prolactin secretion is not known. Here, using in vitro whole-cell patch-clamp recordings, we show that 5-HT hyperpolarizes and abolishes phasic discharge in rat neuroendocrine tuberoinfundibular dopamine (TIDA) neurons, the main inhibitor of prolactin secretion. This process is underpinned by 5-HT 1A receptor-mediated activation of G-protein-coupled inwardly rectifying K ϩ -like currents. We further demonstrate that the SSRIs, fluoxetine and sertraline, directly suppress TIDA neuron activity through parallel effects, independent of 5-HT transmission. This inhibition involves decreased intrinsic excitability and a slowing of TIDA network rhythms. These findings indicate that SSRIs may inhibit neuroendocrine dopamine release through both 5-HT-dependent and -independent actions, providing a mechanistic explanation for, and potential molecular targets for the amelioration of, the hyperprolactinemia and sexual dysfunction associated with these drugs.
Introduction
Selective serotonin reuptake inhibitors (SSRIs) were originally developed for the treatment of mood disorders but have also been approved to treat a widening spectrum of conditions, including anxiety, obsessive compulsive disorder, and bulimia nervosa. Depressive disorders, with a global prevalence exceeding 4% (Vos et al., 2012) , are projected to be the leading cause of disease burden by 2030 (World Health Organisation, 2008) . SSRIs are recommended as a front-line therapy for moderate to severe depression (American Psychiatric Association, 2000) , and population prevalence of SSRI use as high as 3.5% has been described (Olié et al., 2002) . Unfortunately, SSRI compliance is compromised by the high incidence of adverse effects. Sexual side effects, including amenorrhea, infertility, anorgasmia, impotence, and impaired libido, are often under-reported (Montejo-González et al., 1997) but, when systematically assessed, are experienced by ϳ40% of all SSRI users (Clayton et al., 2002) , often leading to cessation of treatment (van Geffen et al., 2007) .
The adverse sexual effects associated with SSRIs are commonly attributed to elevation of the pituitary hormone, prolactin (Safarinejad, 2008; Madhusoodanan et al., 2010) . Prolactin exerts a range of physiological effects that decrease fertility and libido (Bole-Feysot et al., 1998) , and hyperprolactinemia, caused, for example, by pituitary adenomas or induced iatrogenically, results in reproductive dysfunction, such as menstrual disturbances and impotence (e.g., Schlechte et al., 1980; Buvat et al., 1985) . Hyperprolactinemia is common with SSRIs, such as fluoxetine (Prozac) and sertraline (Urban and Veldhuis, 1991; Ekselius et al., 1997; Gregorian et al., 2002; Petit et al., 2003) , and was originally described in animal studies (e.g., Morgan and Herbert, 1978) . Importantly, serotonin (5-HT) itself was first shown to be a potent prolactin-releasing agent Ͼ4 decades ago (Kamberi et al., 1971; Lu and Meites, 1973) .
It is not well understood how 5-HT and SSRIs promote prolactin release (Emiliano and Fudge, 2004) . Direct stimulation of prolactin-producing lactotrophs is unlikely because administration of 5-HT to isolated pituitary preparations does not promote prolactin secretion (Birge et al., 1970) . The release of prolactin is, however, under powerful control by neuroendocrine tuberoinfundibular dopamine (TIDA) neurons located in the hypothalamic arcuate nucleus (Lyons and Broberger, 2014) . Dopamine released from TIDA neurons reaches the pituitary through the portal capillary system and tonically suppresses prolactin release via inhibitory dopamine D2-type receptors. Recent work suggests that neuromodulators and hormones that influence prolactin release and lactation may do this by altering the passive and active membrane properties of TIDA neurons (Lyons et al., 2010 (Lyons et al., , 2012 Briffaud et al., 2015; Zhang and van den Pol, 2015) Here, we have investigated whether 5-HT and three SSRIs (fluoxetine, sertraline, and fenfluramine) can alter the electrophysiology of TIDA cells in a way that may explain the prolactin-releasing actions of these compounds.
Materials and Methods

Animals
Male Sprague Dawley rats (Charles River), 22-to 30-d-old for electrophysiology experiments and 4-to 6-weeks-old for immunofluorescence, were housed with free access to standard chow and tap water in a temperature-controlled environment under 12 h/12 h light/dark conditions. All animal experiments had received prior approval by the local ethical board, Stockholms Norra Djurförsöksetiska Nämnd, and were performed in accordance with the European Communities Council Directive of November 24, 1986 (86/609/EEC) .
Electrophysiology
Electrophysiological experiments were performed as previously described (Lyons et al., 2012) . Rats (n ϭ 83) were anesthetized with sodium pentobarbital and decapitated. The brain was removed and placed in cold, oxygenated (95%O 2 /5%CO 2 ) "slicing" solution containing the following (in mM): 214 sucrose, 2.0 KCl, 1.2 NaH 2 PO 4 , 26 NaHCO 3 , 1.3 MgSO 4 , 2.4 CaCl 2 , and 10 D-glucose. The brain was glued to a vibratome (Leica), and 250 m thick coronal sections of the hypothalamus, including the arcuate nucleus, were prepared. Slices were immediately transferred to a "recording" solution containing the following (in mM): 127 NaCl, 2.0 KCl, 1.2 NaH 2 PO 4 , 26 NaHCO 3 , 1.3 MgCl 2 , 2.4 CaCl 2 , and 10 D-glucose, in a continuously oxygenated holding chamber at 35°C for a period of 25 min. Subsequently, slices were allowed to recover in "recording" solution at room temperature for a minimum of 1 h before recording. For whole-cell recordings, slices were transferred to a submerged chamber and placed on an elevated grid that allows perfusion both above and below the slice. An Axioskop 2 FS Plus upright microscope (Carl Zeiss) was used for infrared-differential interference contrast visualization of cells. Recordings were performed at room temperature (22°C), and slices were continuously perfused with oxygenated "recording" solution (as above) unless otherwise described at a rate of ϳ5 ml/min. All pharmacological compounds were bath applied.
Whole-cell current-and voltage-clamp recordings were performed with pipettes (3-7 M⍀ when filled with intracellular solution) made from borosilicate glass capillaries (World Precision Instruments) pulled on a P-97 Flaming/Brown micropipette puller (Sutter Instruments). The intracellular recording solution contained (in mM) the following: 140 K-gluconate, 10 KCl, 10 HEPES, 1 EGTA, 2 Na 2 ATP, pH 7.3 (with KOH). When investigating IPSCs, a High Cl Ϫ intracellular solution was used comprised of the following (in mM): 150 KCl, 10 HEPES, 1 EGTA, 2 Na 2 ATP), pH 7.3 (with KOH). The concentration used for TTX was 500 nM. In experiments that required the raising of K ϩ conductances, reversal potential high K ϩ extracellular recording solution containing the following (in mM): 127 NaCl, 10 KCl, 1.2 NaH 2 PO 4 , 26 NaHCO 3 , 1.3 MgCl 2 , 2.4 CaCl 2 , 10 D-glucose was used. Recordings were performed using a Multiclamp 700B amplifier and pClamp9 software (Molecular Devices). Access resistance was monitored throughout the experiments, and neurons in which the series resistance was Ͼ25 M⍀ or changed Ͼ15% were excluded from the statistics. Liquid junction potential was 16.4 mV and not compensated. The recorded current was sampled at 10 kHz and filtered at 2 kHz unless otherwise stated. In voltage-clamp experiments, the holding potential was Ϫ60 mV unless otherwise stated.
To determine the 5-HT-induced current in the presence of TTX frequency distribution, histograms were plotted for 10 s of control, 5-HT, and wash traces with Gaussian fits performed on the individual and pooled distributions. The mean difference between the Gaussian peaks for control and 5-HT was used as the value for 5-HT-induced current. The spectral density plot of the underlying oscillation was produced by filtering the trace with a 1 Hz low pass filter and performing spectral analysis with a rectangular window function on 56.5 s segments giving a spectral resolution of 0.019 Hz. To quantify GABAergic synaptic events, 100 s segments in control and during response were selected for analysis and comparison.
Immunofluorescence
Rats (n ϭ 4) were perfused with a fixative of 5% glutaraldehyde/1% sodium bisulfite in cacodylate buffer; 14-m-thick coronal brain sections were processed for indirect immunofluorescence as previously described using mouse monoclonal anti-TH antibodies (1:2000; Millipore) and rabbit anti-serotonin (5-HT) antiserum (1:250; Millipore) (Foo et al., 2014) .
Statistical analysis and reagents
Data analysis was performed with OriginPro8.5 (OriginLab), Clampfit 9 (Molecular Devices), and Mini Analysis 6.0.9 (Synaptosoft) software. Statistical significance was set at p Ͻ 0.05. All reagents were purchased from Sigma Pharmaceuticals, with the exception of TTX, which was purchased from Alomone Labs, and 8-hydroxy PIPAT oxalate (Ϯ)-8-hydroxy-2-dipropylaminotetralin hydrobromide (8-OH-DPAT), NAD299 hydrochloride, fluoxetine hydrochloride, sertraline hydrochloride, and dexfenfluramine hydrochloride, which were purchased from Tocris Bioscience.
Results
5-HT directly inhibits oscillating TIDA neurons
TIDA neurons display a synchronized network oscillation (Lyons et al., 2010 (Lyons et al., , 2012 , characterized by alternating periods of hyperpolarization and depolarization (Fig. 1A) . This stereotyped oscillation provides a reliable electrical signature for rat TIDA neurons in vitro (Lyons et al., 2010 (Lyons et al., , 2012 . When 5-HT (10 M) was applied to TIDA neurons (in current-clamp mode), a reversible hyperpolarization and cessation of both oscillation and phasic discharge were consistently observed (n ϭ 27 of 27; 100%; Fig. 1 A, B) .
Immunohistochemical staining for 5-HT and TH (the ratelimiting enzyme in catecholamine biosynthesis) revealed 5-HTimmunoreactive fibers in close apposition to TIDA somata and dendrites, thus providing an anatomical substrate for the direct 5-HT-ergic modulation of TIDA activity (Fig. 1C) . This was confirmed pharmacologically, as in the presence of the Na ϩ channel blocker TTX (500 nM), which also abolishes the TIDA oscillation (Lyons et al., 2010, 2012), 5-HT (10 M) induced a rapid and reversible 22.9 Ϯ 1.6 mV hyperpolarization (n ϭ 5; p Ͻ 0.005; ANOVA; F (2,12) ϭ 163.4; Fig. 2 A, B) (this value was used as a control 5-HT response for current-clamp tests where paired comparisons were not possible), and a 9.7 Ϯ 2.1% reduction in input resistance (n ϭ 5; p Ͻ 0.01; ANOVA; F (2,12) ϭ 10.7; Fig.  2 A, B) . A second application of 5-HT resulted in a 19.3 Ϯ 2.0 mV (n ϭ 5; p Ͻ 0.01; ANOVA; F (2,12) ϭ 21.8) hyperpolarization (88.0 Ϯ 3.6% of the initial response; n ϭ 5; Fig. 2C ) indicative of small, yet significant, tachyphylaxis. The 5-HT response also demonstrated a degree of dose dependence, with 1 M 5-HT inducing a significant Ϫ5.3 Ϯ 1.2 mV (n ϭ 5, p Ͻ 0.01; t test paired; t ϭ 4.4) hyperpolarization, whereas 250 nM failed to elicit a response (Ϫ0.8 Ϯ .1.1; n ϭ 5; not significant; t test paired; t ϭ 0.7; data not shown). These results demonstrate that 5-HT inhibits TIDA neurons via a direct, postsynaptic mechanism.
5-HT activates a G-protein-coupled inwardly rectifying potassium (GIRK)-like current
The ionic mechanisms underlying the 5-HT-induced hyperpolarization were investigated in voltage clamp. In the presence of TTX, application of 5-HT (10 M) resulted in a reversible outward current of 17.3 Ϯ 2.2 pA (n ϭ 10; p Ͻ 0.005; ANOVA; F (2,27) ϭ 52.4; Fig. 3A ) (this value was used as a control 5-HT response for voltage-clamp tests where paired comparisons were not possible, "Control I 5-HT "). Digital subtraction of voltageclamp ramps performed in control from those at the peak of response revealed the 5-HT-induced current (I 5-HT ) to be a net outward current ( Fig. 3Ai ) with an estimated reversal potential of Ϫ128.1 mV (Fig. 3Aii ), lower than that calculated for K ϩ (Ϫ110.6 mV). As this reversal potential was lower than that predicted for K ϩ , possibly due to the role of gap junctions in the TIDA oscillation (Lyons et al., 2010) and their potential impact on space clamp, we sought to further investigate the role of K ϩ currents in the generation of I 5-HT . Potassium channels were blocked through a Cs ϩ -based internal solution. Here, 5-HT (10 M) application induced only a 5.8 Ϯ 0.7 pA outward current (n ϭ 10; p Ͻ 0.005; t test paired; t ϭ Ϫ8.9; Fig. 3 B, Bi), a significant 66.5 Ϯ 3.8% reduction of the control 5-HT response (n ϭ 10; p Ͻ 0.005 vs control I 5-HT ; t test unpaired; t ϭ 5.1; Fig. 3 A, Bii).
Next, [K ϩ ] o was raised to 10 mM, shifting the calculated K ϩ reversal potential to Ϫ68 mV. At our holding potential of Ϫ60 mV, application of 5-HT (10 M) failed to induce an outward current (1.0 Ϯ 0.6 pA; n ϭ 10; not significant; t test paired; t ϭ 1.7; Fig. 3C ), with I 5-HT exhibiting a reversal potential of Ϫ58.9 mV and mild inward rectification (Fig. 3Ci) . Neuronal hyperpolarization by 5-HT has been associated with activation of GIRK channels (Penington et al., 1993; Lüscher et al., 1997) . To investigate the potential role of GIRK channels, we sequentially applied 5-HT to TIDA neurons in the absence and presence of Ba 2ϩ (300 M), a nonspecific blocker of inwardly rectifying K ϩ channels. In the presence of Ba 2ϩ , 5-HT induced a 6.7 Ϯ 1.5 pA outward current (n ϭ 5; p Ͻ 0.05; t test paired; t ϭ Ϫ4.4; Fig. 3D ), a significant 75.1 Ϯ 6.5% reduction compared with the initial, 29.0 Ϯ 2.5 pA (n ϭ 5), response to 5-HT (n ϭ 5; p Ͻ 0.005; ANOVA; F (2,12) ϭ 35.3; Fig. 3Di ). This reduction was not due to desensitization as following washout of 5-HT and Ba 2ϩ , reapplication of 5-HT induced an outward current of 26.4 Ϯ 2.4 pA (n ϭ 5; p Ͻ 0.005; t test paired; t ϭ Ϫ11.1), which proved indistinguishable from the first response (n ϭ 5; not significant; ANOVA; F (2,12) ϭ 35.3; Fig. 3 D , Di) . The selective GIRK channel blocker Tertiapin Q (TQ), a derivative of the honey bee venom tertiapin (Jin and Lu, 1999) , was also tested. The application of 5-HT in the presence of TQ (300 nM) induced a 9.5 Ϯ 2.2 pA outward current (n ϭ 5; p Ͻ 0.01, t test paired; t ϭ Ϫ4.4 Fig.  3Dii ), a significant 48.5 Ϯ 6.4% reduction compared with the initial, 18 Ϯ 3.1 pA (n ϭ 5), response to 5-HT (n ϭ 5; p Ͻ 0.005, t test paired; t ϭ 4.8; Fig. 3Dii ). Furthermore, preincubation of slices (15-20 min) with the G-protein blocker N-ethylmaleimide (NEM; 250 M) resulted in an 81.9% diminution of the 5-HT control response (3.0 Ϯ 1.0 pA; n ϭ 5; p Ͻ 0.005 vs control I 5-HT ; t test unpaired; t ϭ 4.5; Fig. 3 A, Dii) .
Collectively these results indicate that I 5-HT in TIDA neurons likely involves activation of GIRK-like channels.
5-HT inhibits TIDA neurons via the 5-HT 1A receptor
In vivo studies have implicated 5-HT 1A (Mulroney et al., 1994; Jørgensen et al., 2001) , 5-HT 2A (Liang and Pan, 2000) , and 5-HT 2C (Jørgensen et al., 1992) receptors in 5-HT's modulation of prolactin secretion. The broad-spectrum 5-HT 2 receptor antagonist methiothepin (5 M) failed to block the 5-HT-induced hyperpolarization of TIDA neurons (Control 5-HT Ϫ23.6 Ϯ 1.8 mV vs methiothepin 5-HT Ϫ19.8 Ϯ 2.4 mV; n ϭ 3; not significant; t test paired; t ϭ Ϫ2.4; data not shown). In contrast, the selective 5-HT 1A antagonist, NAD 299 (1 M) completely O n ϭ 10). D, Voltage-clamp trace, oscillating TIDA neuron recorded as in A (there is abolishment of oscillation in response to TTX). 5-HT is applied before, during, and after Ba ϩ is present in the bath. There is Ba ϩ -induced reduction of I 5-HT . Calibration: 10 pA, 60 s. Di, Ba ϩ significantly and reversibly reduces I 5-HT . Box plot organized as Bii (n ϭ 5). Dii, TQ (n ϭ 5) and the G-protein inhibitor NEM (control n ϭ 10, NEM n ϭ 5) significantly reduces I 5-HT . Box plot organized as Bii. ***p Ͻ 0.005. ns, Not significant.
blocked the 5-HT-induced effect (0.3 Ϯ 0.7 pA; n ϭ 12; not significant; t test paired; t ϭ Ϫ0.4; Fig. 4A ), a response statistically different from initial response to 5-HT (20.9 Ϯ 5.2 pA; n ϭ 12; p Ͻ 0.005; ANOVA; F (2,33) ϭ 25.6; Fig. 4Ai ). Incubation with NAD 299 alone did not alter baseline current (Control Ϫ15.1 Ϯ 4.1 pA vs NAD299 Ϫ15.0 Ϯ 4.2 pA; n ϭ 12; not significant; t test paired; t ϭ Ϫ0.17; data not shown).
The 5-HT 1A -selective agonists, 8-OH-PIPAT and 8-OH-DPAT, were also tested. Application of 8-OH-DPAT induced a 20.4 Ϯ 2.0 pA (n ϭ 10; p Ͻ 0.005; t test paired; t ϭ Ϫ10.2; Fig. 4B ) outward current, corresponding to 90.2 Ϯ 3.7% of the initial response to 5-HT (22.8 Ϯ 2.4 pA; n ϭ 10; not significant; t test; t ϭ 1.9; paired; Fig. 4Bi ). 8-OH-PIPAT also induced an outward current that was statistically indistinguishable from the initial response to 5-HT (Initial 5-HT 17.2 Ϯ 2.1 pA vs 8-OH-PIPAT 14.9 Ϯ 2.7 pA; n ϭ 5; not significant; t test paired; t ϭ 1.6; Fig.  4C ,Ci). As peak response for 8-OH-PIPAT and 8-OH-DPAT often took time to stabilize and to ensure that it involved opening of GIRK-like channels, 8-OH-PIPAT was coapplied with Ba 2ϩ , under which conditions it induced a significantly reduced outward current compared with initial response to 5-HT (Initial 5-HT 23.7 Ϯ 4.6 vs Ba 2ϩ PIPAT 2.8 Ϯ 0.6 pA; n ϭ 9; p Ͻ 0.005; ANOVA; F (2,24) ϭ 20.2; Fig. 4 D, Di) . However, subsequent removal of Ba 2ϩ revealed the 5-HT 1A -mediated outward current, which proved indistinguishable from the initial response to 5-HT (20.0 Ϯ 4.6 pA; n ϭ 9; not significant; ANOVA; F (2,24) ϭ 20.2; Fig.  4 D, Di) . Unlike the effects of 5-HT, which were readily reversible, the response of TIDA neurons to 8-OH-PIPAT and 8-OH-DPAT did not recover in either voltage (n ϭ 24 of 24) or current clamp (n ϭ 6 of 6; Fig. 4E ), with the 5-HT 1A agonists having been washed from the recording chamber for a minimum of 15 min (Fig. 4E) .
5-HT decreases the frequency of spontaneous and miniature IPSCs
Having established postsynaptic effects, we investigated whether 5-HT could modulate TIDA spontaneous IPSCs (sIPSCs). Using high Cl Ϫ pipette solution and in the presence of CNQX and AP-V to block glutamatergic events, we analyzed and compared sIPSCs from a 100 s segment before application of 5-HT with sIPSCs from a 100 s segment during response. Application of 5-HT induced a reversible increase in sIPSC interevent interval (IEI; control 460.8 Ϯ 94.2 ms, 5-HT 1935.7 Ϯ 358.9 ms, washout 604.1 Ϯ 111.4 ms; n ϭ 11; p Ͻ 0.005; ANOVA; F (2,30) ϭ 25.6; Fig. 5A-D) . To determine the effect of 5-HT on miniature IPSCs (mIPSCs), TIDA neurons were recorded as above but in the presence of TTX. Under these conditions, 5-HT did not affect mIPSC amplitude (control 60.6 Ϯ 5.9 pA vs 5-HT 61.2 Ϯ 5.4 pA; n ϭ 5; not significant; t test paired; t ϭ Ϫ0.14; Fig. 6A-D) but did increase IEI (Control 563.5 Ϯ 92.6 ms vs 5-HT 1593.3 Ϯ 197.3 ms; n ϭ 5; p Ͻ 0.005; t test paired; t ϭ Ϫ6.8; Fig. 6A-D) . These results suggest that 5-HT reduces GABA release onto TIDA neurons, without affecting postsynaptic responsiveness to GABA.
Clinically relevant doses of fluoxetine inhibit TIDA neurons' capacity for repetitive discharge and reduce action potential (AP) amplitude Like 5-HT, SSRIs, such as fluoxetine (Prozac; Flx), increase plasma levels of prolactin in animals (e.g., Morgan and Herbert, 1978) and humans (e.g., Meltzer et al., 1979) . Although SSRIs would, by enhancing ambient 5-HT, modulate TIDA output indirectly via the 5-HT mechanism described above, we sought to determine whether SSRIs could further modulate TIDA activity via a direct, 5-HT-independent mechanism. To this end, we again used our hypothalamic slice preparation, which, being rapidly perfused and having neither 5-HT cell bodies nor a means to stimulate deafferented 5-HT fibers, will have reduced 5-HT reuptake for SSRIs to block. As therapeutic concentrations of Flx in the brain are as high as ϳ30 M (Karson et al., 1993), we tested TIDA neurons with prolonged (60 min) exposure to Flx at a concentration of 25 M. In contrast to 5-HT, under this challenge, TIDA oscillations endured, undergoing only slight changes in amplitude (Control 29.20 Ϯ 2.39 mV vs Flx 60 min 23.84 Ϯ 1.74 mV; n ϭ 7; p Ͻ 0.01; t test paired; t ϭ 5.9; Fig. 7 A, B) and frequency (Control 0.059 Ϯ 0.007 Hz vs Flx 60 min 0.072 Ϯ 0.005 Hz; n ϭ 7; p Ͻ 0.05; t test paired; t ϭ Ϫ3.3; Fig. 7 A, B) . Intrinsic excitability was, however, severely diminished, as assessed by square-form current injection (20 pA, 500 ms) triggered from a membrane potential of Ϫ50 mV. Application of Flx reduced the depolarization-triggered AP number from 9.2 Ϯ 1.2 to 1 (n ϭ 6; p Ͻ 0.005; t test paired; t ϭ 7; Fig 7C-E) , most prominently after 60 min of drug exposure. AP waveform was also affected, with amplitude of the initial AP being reduced from 96.3 Ϯ 2.3 mV in control to 31.7 Ϯ 3.8 mV at t ϭ 60 min (n ϭ 6; p Ͻ 0.005; t test paired; t ϭ 12.6; Fig. 7C,D) . Threshold (Control Ϫ39.2 Ϯ 0.7 mV; Flx 60 min Ϫ33.2 Ϯ 1.3 mV; n ϭ 6; p Ͻ 0.05; t test paired; t ϭ Ϫ4.3; Fig. 7C ) and half-width (Control 1.5 Ϯ 0.1 ms; Flx 60 min 4.6 Ϯ 0.5ms; n ϭ 6; p Ͻ 0.005; t test paired; t ϭ Ϫ5.6; Fig. 7C ) were also affected.
With higher doses of Flx (100 M), voltage-clamp recordings of TIDA neurons revealed a gradual reduction in cycle amplitude and increase in cycle duration, with the oscillation being completely abolished after 28.2 Ϯ 3.1 min of continuous exposure (n ϭ 10/10; Fig. 8A-D) . Despite our recording conditions and use of a reduced preparation, there still remained the possibility that, rather than a 5-HT-independent effect, Flx's ability to abolish the TIDA oscillation was the consequence of either, 5-HT accumulation, or the dialysis of intracellular contents associated with prolonged whole-cell recording. To control for 5-HT accumulation, Flx was applied in the presence of NAD299, blocking 5-HT's effect at the 1A receptor (identified above as the mediator of direct electrophysiological actions of 5-HT on TIDA neurons) and presumably the effect of any increase in ambient 5-HT. These voltage-clamp recordings showed that prolonged application of Flx (100 M) still abolished the TIDA oscillation (n ϭ 7 of 7; 18.4 Ϯ 2.4 min; Fig. 9A ). In current clamp, Flx at the lower dose of 25 M, applied in the presence of NAD299, continued to inhibit intrinsic excitability, reducing depolarization-induced AP number from 7.4 Ϯ 0.5 to 1.5 Ϯ 0.7 (n ϭ 8; p Ͻ 0.005; t test paired; t ϭ 6.6; Fig. 9B ). We took a number of different approaches to control for potential effects of intracellular dialysis. In the cell-attached recording configuration, thus preserving the neuron's internal milieu, Flx (100 M) also abolished TIDA AP discharge (n ϭ 7/7; 15.1 Ϯ 2.1 min; Fig. 9C ). Second, whole-cell recordings of oscillating TIDA neurons were made after a 30 min incubation with Flx (25 M), and their intrinsic excitability was compared with TIDA neurons recorded without exposure to Flx. This challenge also saw a reduction in intrinsic excitability with depolarization-induced AP discharge decreasing from 7.0 Ϯ 0.6 APs in control neurons (n ϭ 6) to 1.7 Ϯ 0.5 APs in Flx-incubated neurons (n ϭ 6; p Ͻ 0.005; t test unpaired; t ϭ 8; Fig. 9D ). Furthermore, when performed in the whole-cell configuration, prolonged (Ͼ60 min) control voltage-and current-clamp recordings (i.e., in the absence of any drug application) demonstrated that TIDA neurons maintain their oscillations (n ϭ 9 of 9; Figure 3A (note abolishment of oscillation in response to TTX). Following a first exposure to 5-HT, eliciting a reversible outward current, Ba ϩ (300 M) is bath applied to the cell. Note the absence of a response to 8-OH PIPAT (compare C) in the presence of Ba ϩ and how, as a consequence of the enduring nature of its interaction with the 5HT-1A receptor, the drug response is fully uncovered following wash of Ba ϩ from the recording chamber. Calibration: 20 pA, 60 s. Di, Ba ϩ significantly and reversibly reduces I 8-OH-PIPAT . Box plot organized as Figure 3Bii (n ϭ 9) . E, Current-clamp, application of 8-OH-PIPAT induces cessation of oscillation and AP discharge. There is lack of recovery following wash of 8-OH-PIPAT. Calibration 20 mV 60 s. ***p Ͻ 0.005. ns, Not significant. Fig. 9 E, F ) and capacity for repetitive discharge (n ϭ 6 of 6; Fig  9F ) . Collectively, the results from these experiments support the contention that Flx's ability to disrupt TIDA neurons' network oscillation and discharge pattern is independent of 5-HT's effects at the 1A receptor and the cellular dialysis associated with wholecell recording. amplitude, capacity for repetitive discharge, and oscillatory activity (Fig. 10A,B) . AP number was reduced from 7.75 Ϯ 0.75 to 1.75 Ϯ 0.75 per test pulse (n ϭ 4; p Ͻ 0.05; t test paired; t ϭ 8.5; AP number fell to 1 in 3 of 4 neurons tested) and amplitude of the initial AP was reduced from 93.7 Ϯ 2.1 mV to 41.8 Ϯ 10.1 mV (n ϭ 4; p Ͻ 0.05; t test paired; t ϭ 4.4). Oscillatory activity was abolished in 4 of 4 neurons after 39.6 Ϯ 6.1 min (Fig. 10B) . Fenfluramine (20 M), in contrast, abolished oscillation activity more rapidly than the other Figure 6 . Serotonin inhibits mIPSCs in TIDA neurons via a presynaptic mechanism. A, Voltage-clamp trace showing mIPSCs from an oscillating TIDA neuron, isolated as in Fig. 5A , but with TTX added to abolish AP discharge. Application of 5-HT reversibly induces an outward current and a decrease in mIPSC frequency. Calibration: 40 pA, 20 s. Bi, Bii, Rise aligned mIPSCs (gray) with averaged event superimposed from boxed areas in A. Green represents Control. Red represents 5-HT. 5-HT application fails to alter mean mIPSC amplitude. Calibration: 30 pA, 10 ms. Biii, Biv, Enlarged views of the 100 s sections boxed in A with corresponding raster plots above. Green represents Control. Red represents 5-HT. Calibration: 40 pA, 5 s. C, Cumulative probability curves of mIPSCIEIs generated from the control (green) and 5-HT (red) sections boxed in A. The distribution shifts to significantly greater IEIs (K-S2; p Ͻ 0.001). D, 5-HT reversibly and significantly increases mIPSC IEI (green), whereas amplitude remains unchanged (red). Thick lines indicate mean Ϯ SEM. Dashed lines indicate raw data (n ϭ 5). ns, Not significant.
SSRIs tested (11.6 Ϯ 2.6 min; n ϭ 5; p Ͻ 0.05; ANOVA; F (2,11) ϭ 11.0; Fig. 10C,D) but following 60 min of exposure did not significantly reduce either AP number (5.3 Ϯ 0.7 in control, 3.3 Ϯ 1.5 in fenfluramine; n ϭ 3; not significant; t test paired, t ϭ 1.3) or the amplitude of the initial AP (99.3 Ϯ 3.8 mV in control, 87.0 Ϯ 7.2 mV in fenfluramine; n ϭ 3; not significant; t test paired; t ϭ 3).
Discussion
The ability of 5-HT and SSRIs to stimulate prolactin release was first described Ͼ40 years ago (Lu and Meites, 1973; Emiliano and Fudge, 2004) . The hyperprolactinemia induced by many SSRIs has been linked to the sexual side effects associated with these , 1991; Amsterdam et al., 1997; Ekselius et al., 1997) , which are common and sufficiently debilitating to cause drug withdrawal in many patients (Montejo et al., 2001; van Geffen et al., 2007 ). Yet, how 5-HT and SSRIs stimulate prolactin release is not well understood. Here we show that 5-HT activates a K ϩ conductance to directly hyperpolarize and inhibit the firing of rat TIDA neurons in vitro. We further show that fluoxetine and sertraline also decrease TIDA excitability, but that the cellular mechanisms, as revealed by recordings in a deafferented slice preparation lacking serotonergic neurons and in the continued presence of the 5-HT 1A antagonist NAD299, are likely different from those through which 5-HT acts.
drugs (Urban and Veldhuis
The outward current activated by 5-HT was mimicked by application of 8-OH-PIPAT and 8-OH-DPAT and was blocked by prior application of NAD299, indicating that it is mediated by 5-HT 1A receptors. I 5-HT displays characteristics of a GIRK current with its hyperpolarized reversal potential, inward rectification, sensitivity to [Cs ϩ ] i and [K ϩ ] o , and inhibition by Ba 2ϩ , the GIRK blocker, TQ, and the G-protein uncoupling agent, NEM. A GIRK-like current modulated by opioid and GABA B agonists has been described in TIDA neurons (Loose et al., 1990) , and GIRK channel subunits are strongly expressed in the arcuate nucleus (Saenz del Burgo et al., 2008) . Moreover, coupling of the 5-HT 1A receptor to GIRK channels has previously been reported in hippocampal (Lü scher et al., 1997) and raphe (Penington et al., 1993) neurons, and mRNAs encoding these proteins are frequently coexpressed (Saenz del Burgo et al., 2008) .
We thus propose that 5-HT-induced hyperpolarization, underpinned by a 5-HT 1A receptor-mediated opening of GIRK-like channels, abolishes TIDA neuron discharge, which in turn reduces dopamine release in the portal capillaries. As such, the inhibitory D2R "brake" on lactotrophs is relieved, resulting in the secretion of prolactin into the general circulation. This scenario is in agreement with reports that 5-HT agonists, at concentrations that stimulate prolactin release, decrease the levels of dopamine in the TIDA-pituitary axis (Pilotte and Porter, 1981) and fail to increase prolactin when dopamine synthesis has been blocked (Quattrone et al., 1979) . There is also evidence that 5-HT stimulates the release of a prolactin-releasing factor (Clemens et al., 1978; Pilotte and Porter, 1981) , possibilities that are not mutually exclusive. The persistence of the 5-HT-induced hyperpolarization in the presence of TTX and the presence of 5-HT terminals on TIDA cell bodies (confirming Bosler et al., 1984; Kiss and Halász, 1986) demonstrates direct, postsynaptic actions of 5-HT on TIDA cells. We also show, however, a decrease in presynaptic inhibitory inputs in response to 5-HT. This finding is perhaps best explained by anatomical evidence that TIDA neurons are GABAergic (Everitt et al., 1984) and may auto-innervate (Léránth et al., 1985) , and also indicates the existence of 5-HT receptors on the axon terminal as well as the somatodendritic compartment of TIDA neurons. Thus, the loss of IPSCs may primarily reflect abolishment of TIDA discharge, further attesting to the powerful inhibition of the system by 5-HT. Modulation of non-TIDA-derived GABAergic input by 5-HT can, however, not be excluded.
Fluoxetine and other SSRIs were developed based on the hypothesis that hypoactivity of central serotonergic transmission underlies depression (see Wong et al., 1995) . Given Flx's proven ability to increase ambient 5-HT, its prolactin-releasing effects in the whole animal would then be expected to depend on serotonin's ability to inhibit TIDA output. Accordingly, in a situation with little or no 5-HT release or accumulation (such as in our deafferented, rapidly perfused slice), or in the continued presence of the 5-HT 1A antagonist NAD299, SSRIs would fail to inhibit TIDA neurons. However, this was clearly not the case, as during exposure to clinically relevant concentrations (25 M) (Karson et al., 1993) of Flx, the intrinsic excitability of TIDA neurons was powerfully blunted with decreased AP amplitude and reduced capacity for repetitive discharge. Notably, however, the oscillation as such persisted, in sharp contrast to its abolishment in the presence of 5-HT. At 100 M Flx, the oscillation disappeared, but with a strikingly different temporal profile to 5-HT, a response preserved despite 5-HT 1A receptor blockade. Furthermore, similar effects were seen with sertraline and fenfluramine.
How can these apparently 5-HT-independent effects be explained? A solution can be found in the accumulating evidence for off-target (i.e., nonserotonergic) actions of SSRIs documented in the literature (see Bianchi, 2008) . Studies in other systems have revealed that Flx can directly modulate particular membrane currents, including those carried by K ϩ (e.g., Tytgat et al., 1997), Ca 2ϩ (e.g., Deák et al., 2000) , and Cl Ϫ (e.g., Steele et al., 2005) . Of particular relevance to the present results, Flx has been shown to attenuate both persistent (I NaP ) and transient sodium currents (I NaT ), inhibiting repetitive discharge and oscillatory activity in olfactory bulb neurons with a time course very similar to that shown here (Igelström and Heyward, 2012) . In TIDA neurons, I NaP is an important contributor to regenerative firing, as evidenced by the abolishment of oscillatory activity by the I NaP blocker TTX, independent of this compound's effects on presynaptic input (Lyons et al., 2010; and unpublished observations) . Thus, the decreased intrinsic excitability observed in TIDA neurons after application of Flx and sertraline may be due to inhibitory actions of these drugs on I NaP . (It may be noted, in this context, that fenfluramine, which in addition to suppressing reuptake also stimulates nonexocytotic release of 5-HT [Kannengiesser et al., 1976] , exerted an effect on a timescale more akin to 5-HT).
Thus, we propose that SSRIs promote prolactin release in vivo through two distinct actions on the TIDA network, both resulting in decreased DA output. First, by increasing 5-HT tone, SSRIs promote 5-HT 1A /GIRK-mediated hyperpolarization. Second, in a 5-HT-independent manner, SSRIs reduce TIDA intrinsic excitability by inhibiting oscillatory activity and AP discharge, via reductions in I NaT and I NaP , respectively. Combined, these actions would result in a shutdown of the TIDA system, causing an increase in prolactin secretion. The present data thus highlight a novel mechanism for the hyperprolactinemia and sexual side effects of SSRIs. It should be noted that acute drug applications to slice preparations of TIDA from the young male rat offers far from a perfect model of the clinical situation where SSRIs are prescribed for long periods to a large and heterogeneous pop- Figure 10 . Sertraline abolishes both the TIDA oscillation and capacity for repetitive discharge, whereas fenlfuramine abolishes the TIDA oscillation but leaves the capacity for repetitive discharge intact. A, Current-clamp recording of an oscillating TIDA neuron. The response of the cell to injection of square-form-positive current pulses of constant size is tested at regular intervals (e.g., at asterisks). Prolonged bath application of sertraline results in gradual abolishment of oscillatory activity and reduction ulation for several diagnoses. The ability of these compounds to elevate circulating prolactin is also less robust when assessed in human subjects than in inbred experimental rodents. Yet, hyperprolactinemia, as well as adverse reproductive effects, are notably common when rigorously assessed in SSRItreated patients (Montejo-González et al., 1997; Clayton et al., 2002) . Thus, these results may be of importance for the development of antidepressant therapies with minimized reproductive side effects and consequently enhanced patient compliance.
